Not estimable in the model [BE/BA News]

posted by The user – Russia, 2017-03-14 13:13 (2156 d 08:52 ago) – Posting: # 17154
Views: 21,603

❝ Try a type I model with Group before Subjects, then you'll get something that is estimable, I believe.

Thank you for your reply.

Sorry, but I did not catch the idea. Should I try this model: Group+Patient(Sequence)+Sequence+Period+Treatment?

One more comment: the groups are unbalanced. Type I is suiatable for balanced groups as I undertood. Looks like I could not use the Type I model.

Complete thread:

UA Flag
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
12 visitors (0 registered, 12 guests [including 6 identified bots]).
Forum time: 22:06 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz